Kimer Med - Crunchbase Company Profile & Funding

Q: Where is Kimer Med's headquarters?

Kimer Med is located in Nelson, Nelson, New Zealand.

Q: Who invested in Kimer Med?

Kimer Med is funded by Callaghan Innovation.

Q: When was the last funding round for Kimer Med?

Kimer Med closed its last funding round on obfuscated from a Grant round.

Q: How much funding has Kimer Med raised to date?

Kimer Med has raised obfuscated.

Overview

Kimer Med

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Kimer Med

CB Rank

123904

Broad-spectrum antiviral drug development

Founded

obfuscation

Private

Grant

Nelson, Nelson, New Zealand

1-10

kimermed.co.nz

Biopharma

Biotechnology

Therapeutics

Funding Rounds

Grant

OBF

obfuscation

Series A

OBF

obfuscation

Grant

OBF

obfuscation

Details

Legal Name

Kimer Med Limited

Operating Status

Active

Company Type

For Profit

Founders

Philip Oliver, Richard Kiessig

About the Company

Kimer Med is developing a family of broad-spectrum antiviral therapeutics. Our first targets are the Dengue virus and pandemic preparedness. We closed our Series A capital raise in Oct 2024.

Contact Email

contact@kimermed.co.nz

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Awards

Products & Services

VTose Antiviral Platform

A proprietary platform for developing broad-spectrum antiviral drugs that target long strands of dsRNA produced by viruses during their replication cycle, triggering apoptosis to stop virus replication.

Broad-Spectrum Antivirals

A family of antiviral drugs designed to treat a wide range of viral diseases and provide pandemic protection by targeting common viral mechanisms.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Kimer Med	1	obfuscated obfuscation	Callaghan Innovation	Grant
obfuscated obfuscation	Grant - Kimer Med	1	obfuscated obfuscation	Callaghan Innovation	Grant
obfuscated obfuscation	Grant - Kimer Med	1	obfuscated obfuscation	Callaghan Innovation	Grant
obfuscated obfuscation	Grant - Kimer Med	1	obfuscated obfuscation	Callaghan Innovation	Grant
obfuscated obfuscation	Grant - Kimer Med	1	obfuscated obfuscation	Callaghan Innovation	Grant

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Kimer Med	1	obfuscated obfuscation	Callaghan Innovation	Grant
obfuscated obfuscation	Grant - Kimer Med	1	obfuscated obfuscation	Callaghan Innovation	Grant
obfuscated obfuscation	Grant - Kimer Med	1	obfuscated obfuscation	Callaghan Innovation	Grant
obfuscated obfuscation	Grant - Kimer Med	1	obfuscated obfuscation	Callaghan Innovation	Grant
obfuscated obfuscation	Grant - Kimer Med	1	obfuscated obfuscation	Callaghan Innovation	Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Callaghan Innovation	Yes	Grant - Kimer Med	—
Callaghan Innovation	Yes	Grant - Kimer Med	—
Callaghan Innovation	Yes	Grant - Kimer Med	—
Callaghan Innovation	Yes	Grant - Kimer Med	—
Callaghan Innovation	Yes	Grant - Kimer Med	—